Bryan White, PharmD, FIDSA, BCIDP
@bryanpwhite.bsky.social
ID Pharmacist and PGY2 ID RPD in OKC at University of Oklahoma Medical Center
Excited to hear more details about the SNAP and CloCeBa trials for MSSA bacteremia being presented at ESCMID this afternoon. Looks like a win for team cefazolin. It will be practice changing with the current variations in practice for treating MSSA BSI. #ESCMID
April 12, 2025 at 10:50 AM
Excited to hear more details about the SNAP and CloCeBa trials for MSSA bacteremia being presented at ESCMID this afternoon. Looks like a win for team cefazolin. It will be practice changing with the current variations in practice for treating MSSA BSI. #ESCMID
Our new paper on vancomycin AUC dosing in obesity is out. It showed decreased AKI in obese patients using AUC dosing as compared to trough dosing. Rates of AKI were lower in the AUC group compared to the trough group (11.3% versus 25.2%, p<0.001). This work was led by Corey Guidry .
academic.oup.com
April 4, 2025 at 3:20 PM
Our new paper on vancomycin AUC dosing in obesity is out. It showed decreased AKI in obese patients using AUC dosing as compared to trough dosing. Rates of AKI were lower in the AUC group compared to the trough group (11.3% versus 25.2%, p<0.001). This work was led by Corey Guidry .
The PGY2 in ID at OU didn’t match and is going into phase 2. Please help spread the word! pharmacy.ouhsc.edu/programs/res...
Infectious Diseases - OU College of Pharmacy
pharmacy.ouhsc.edu
March 20, 2025 at 10:13 PM
The PGY2 in ID at OU didn’t match and is going into phase 2. Please help spread the word! pharmacy.ouhsc.edu/programs/res...
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care.
Tracks come with option for 12-credit certificates, covered by the program:
medicine.ouhsc.edu/academic-dep...
🧵
#IDSky #TxID
Tracks come with option for 12-credit certificates, covered by the program:
medicine.ouhsc.edu/academic-dep...
🧵
#IDSky #TxID
Curriculum
medicine.ouhsc.edu
February 11, 2025 at 12:54 PM
Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care.
Tracks come with option for 12-credit certificates, covered by the program:
medicine.ouhsc.edu/academic-dep...
🧵
#IDSky #TxID
Tracks come with option for 12-credit certificates, covered by the program:
medicine.ouhsc.edu/academic-dep...
🧵
#IDSky #TxID
Kinda of a crazy night. Went out for ice cream and ran into Oklahoma’s US senator, James Lankford. Talked for 2 minutes about RFK. Nice conversation with a thoughtful politician. #IDsky
February 1, 2025 at 3:40 AM
Kinda of a crazy night. Went out for ice cream and ran into Oklahoma’s US senator, James Lankford. Talked for 2 minutes about RFK. Nice conversation with a thoughtful politician. #IDsky
Reposted by Bryan White, PharmD, FIDSA, BCIDP
PLEASE SHARE WIDELY #medsky #IDsky #obgynsky #pedsky
CDC STI treatment guidelines have been taken down. They are archived here 👇
web.archive.org/web/20250131...
CDC STI treatment guidelines have been taken down. They are archived here 👇
web.archive.org/web/20250131...
Site Index
STIs are common. Many are curable - all are preventable.
web.archive.org
February 1, 2025 at 2:09 AM
PLEASE SHARE WIDELY #medsky #IDsky #obgynsky #pedsky
CDC STI treatment guidelines have been taken down. They are archived here 👇
web.archive.org/web/20250131...
CDC STI treatment guidelines have been taken down. They are archived here 👇
web.archive.org/web/20250131...
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Post-hoc analysis of 📷 📷 study in MSSA/MRSA bacteremia:
Persistent fever = indicator for complicated infection
Fever on Day 4️⃣: aOR (3.7 (95% CI: 1.58-8.67)) mortality
Fever on Day 7️⃣: aOR: (8.78 (95% CI: 2.78-27.7)
🚫 assn between ⬆️CRP/WBC and mortality
#IDSky
academic.oup.com/ofid/advance...
Persistent fever = indicator for complicated infection
Fever on Day 4️⃣: aOR (3.7 (95% CI: 1.58-8.67)) mortality
Fever on Day 7️⃣: aOR: (8.78 (95% CI: 2.78-27.7)
🚫 assn between ⬆️CRP/WBC and mortality
#IDSky
academic.oup.com/ofid/advance...
Association of daily body temperature, white blood cell count, and C-reactive protein with mortality and persistent bacteremia in patients with Staphylococcus aureus bacteremia: a post-hoc analysis of...
AbstractIntroduction. Classification of patients with Staphylococcus aureus bacteremia (SAB) as complicated versus uncomplicated is based on a combination
academic.oup.com
January 31, 2025 at 2:33 AM
Post-hoc analysis of 📷 📷 study in MSSA/MRSA bacteremia:
Persistent fever = indicator for complicated infection
Fever on Day 4️⃣: aOR (3.7 (95% CI: 1.58-8.67)) mortality
Fever on Day 7️⃣: aOR: (8.78 (95% CI: 2.78-27.7)
🚫 assn between ⬆️CRP/WBC and mortality
#IDSky
academic.oup.com/ofid/advance...
Persistent fever = indicator for complicated infection
Fever on Day 4️⃣: aOR (3.7 (95% CI: 1.58-8.67)) mortality
Fever on Day 7️⃣: aOR: (8.78 (95% CI: 2.78-27.7)
🚫 assn between ⬆️CRP/WBC and mortality
#IDSky
academic.oup.com/ofid/advance...
Reposted by Bryan White, PharmD, FIDSA, BCIDP
There is a director of pharmacy position open at Bartlett Regional Hospital in Juneau, Alaska. Oversees ~25 rx employees in a 55 bed hospital in Alaska's capital and largest town in Southeast Alaska. I work there several times a year, happy to answer any questions. Spread far and wide!
January 7, 2025 at 7:43 AM
There is a director of pharmacy position open at Bartlett Regional Hospital in Juneau, Alaska. Oversees ~25 rx employees in a 55 bed hospital in Alaska's capital and largest town in Southeast Alaska. I work there several times a year, happy to answer any questions. Spread far and wide!
Reposted by Bryan White, PharmD, FIDSA, BCIDP
A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC:
https://doi.org/10.1093/jacamr/dlae144
#JACAMRNews @bryanpwhite.bsky.social
https://doi.org/10.1093/jacamr/dlae144
#JACAMRNews @bryanpwhite.bsky.social
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemia
AbstractObjectives. To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify
doi.org
December 27, 2024 at 11:00 AM
A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC:
https://doi.org/10.1093/jacamr/dlae144
#JACAMRNews @bryanpwhite.bsky.social
https://doi.org/10.1093/jacamr/dlae144
#JACAMRNews @bryanpwhite.bsky.social
Reposted by Bryan White, PharmD, FIDSA, BCIDP
UPMC Western Maryland is looking for a full time stewardship pharmacist. Come work with a truly amazing local team and have system support from Tina Khadem, myself, and ~40 other pharmacists! (also - no holidays, no weekends!)
#idsky #amssky #pharmsky #medsky
sidp.mcjobboard.net/jobs/173869
#idsky #amssky #pharmsky #medsky
sidp.mcjobboard.net/jobs/173869
Infectious Disease Clinical Pharmacist Specialist
UPMC Western Maryland is seeking a highly motivated Infectious Disease Clinical Pharmacist to lead its Antimicrobial Stewardship Program.
UPMC Western Maryland is a 224-bed nonprofit, acute care hospi...
sidp.mcjobboard.net
December 17, 2024 at 11:18 PM
UPMC Western Maryland is looking for a full time stewardship pharmacist. Come work with a truly amazing local team and have system support from Tina Khadem, myself, and ~40 other pharmacists! (also - no holidays, no weekends!)
#idsky #amssky #pharmsky #medsky
sidp.mcjobboard.net/jobs/173869
#idsky #amssky #pharmsky #medsky
sidp.mcjobboard.net/jobs/173869
Reposted by Bryan White, PharmD, FIDSA, BCIDP
🔥🆕️CACTUS
Multi center real world data on ceftaz/avi vs ceftol/tazo for MDR PsA bacteremia or pneumonia
Overall similar clinical success including mortality, recurrent infection & resistance #idsky #EMIMCC #medsky
www.thelancet.com/journals/lan...
Multi center real world data on ceftaz/avi vs ceftol/tazo for MDR PsA bacteremia or pneumonia
Overall similar clinical success including mortality, recurrent infection & resistance #idsky #EMIMCC #medsky
www.thelancet.com/journals/lan...
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
Treatment with ceftolozane–tazobactam resulted in higher rates of clinical success compared with ceftazidime–avibactam for invasive infections due to multidrug-resistant P aeruginosa. Differences were driven by improved response rates for patients with pneumonia who were treated with ceftolozane–tazobactam. There were no significant differences between study groups with respect to all-cause mortality; treatment-emergent resistance was common with both agents.
www.thelancet.com
December 17, 2024 at 1:47 AM
🔥🆕️CACTUS
Multi center real world data on ceftaz/avi vs ceftol/tazo for MDR PsA bacteremia or pneumonia
Overall similar clinical success including mortality, recurrent infection & resistance #idsky #EMIMCC #medsky
www.thelancet.com/journals/lan...
Multi center real world data on ceftaz/avi vs ceftol/tazo for MDR PsA bacteremia or pneumonia
Overall similar clinical success including mortality, recurrent infection & resistance #idsky #EMIMCC #medsky
www.thelancet.com/journals/lan...
Reposted by Bryan White, PharmD, FIDSA, BCIDP
First post on #IDSky
We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025.
Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with!
DM me for details!
medicine.ouhsc.edu/academic-dep...
We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025.
Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with!
DM me for details!
medicine.ouhsc.edu/academic-dep...
Fellowship Opportunities
medicine.ouhsc.edu
December 15, 2024 at 1:29 AM
First post on #IDSky
We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025.
Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with!
DM me for details!
medicine.ouhsc.edu/academic-dep...
We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025.
Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with!
DM me for details!
medicine.ouhsc.edu/academic-dep...
Reposted by Bryan White, PharmD, FIDSA, BCIDP
registration is OPEN for the @sidpharm.bsky.social @escmid.bsky.social PK PD conference!
we can’t wait to see you this summer!
#idsky #pharmsky #amssky #medsky
sidp.org/event-5963379
we can’t wait to see you this summer!
#idsky #pharmsky #amssky #medsky
sidp.org/event-5963379
SIDP - SIDP Inaugural PK/PD Workshop
sidp.org
December 13, 2024 at 10:00 PM
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Pre-exposure prophylaxis (PreP) is an effective strategy to prevent HIV infection. However, lack of adherence to daily oral therapy is a major reason for failure in preventing HIV infection. Read about two large RCTs on twice-yearly lenacapavir https://buff.ly/3OTO5CE #HIVsky #IDsky
December 12, 2024 at 3:51 PM
Pre-exposure prophylaxis (PreP) is an effective strategy to prevent HIV infection. However, lack of adherence to daily oral therapy is a major reason for failure in preventing HIV infection. Read about two large RCTs on twice-yearly lenacapavir https://buff.ly/3OTO5CE #HIVsky #IDsky
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Having a blast learning at ASHP (with @bryanpwhite.bsky.social) and exploring NOLA-Sazerac house, City Park lights
December 12, 2024 at 8:58 PM
Having a blast learning at ASHP (with @bryanpwhite.bsky.social) and exploring NOLA-Sazerac house, City Park lights
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Great ID expert session on optimal invasive Candidiasis diagnostics & mgmt from @bryanpwhite.bsky.social & Daniel Chastain at #ASHP24
December 8, 2024 at 8:16 PM
Great ID expert session on optimal invasive Candidiasis diagnostics & mgmt from @bryanpwhite.bsky.social & Daniel Chastain at #ASHP24
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Wonderful insight from @athenalvhobbs.bsky.social & @bryanpwhite.bsky.social on oral therapies for bloodstream infections due to a urinary source at ASHP! Pop girlies & ID unite for the TSwift support of PO! 💞💊 #ASHP24
December 10, 2024 at 5:03 PM
Wonderful insight from @athenalvhobbs.bsky.social & @bryanpwhite.bsky.social on oral therapies for bloodstream infections due to a urinary source at ASHP! Pop girlies & ID unite for the TSwift support of PO! 💞💊 #ASHP24
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Reposted by Bryan White, PharmD, FIDSA, BCIDP
🚨📣 @sidpharm.bsky.social the Board and Programs Committee want to hear from you! Please take 2 minutes to fill out the member survey for 2025 planning before Friday: www.cognitoforms.com/SIDP1/_2025S...
December 2, 2024 at 8:16 PM
🚨📣 @sidpharm.bsky.social the Board and Programs Committee want to hear from you! Please take 2 minutes to fill out the member survey for 2025 planning before Friday: www.cognitoforms.com/SIDP1/_2025S...
Reposted by Bryan White, PharmD, FIDSA, BCIDP
What's the best duration for treating uncomplicated P. aeruginosa-BSI?
This metaanalysis of observational studies (n=1746)
found no differences in recurrence+mortality for short (<10d) compared to prolonged treatments.
📖 www.journalofhospitalinfection.com/article/S019...
#PsWatch #AMSsky #IDsky
This metaanalysis of observational studies (n=1746)
found no differences in recurrence+mortality for short (<10d) compared to prolonged treatments.
📖 www.journalofhospitalinfection.com/article/S019...
#PsWatch #AMSsky #IDsky
November 24, 2024 at 4:11 PM
What's the best duration for treating uncomplicated P. aeruginosa-BSI?
This metaanalysis of observational studies (n=1746)
found no differences in recurrence+mortality for short (<10d) compared to prolonged treatments.
📖 www.journalofhospitalinfection.com/article/S019...
#PsWatch #AMSsky #IDsky
This metaanalysis of observational studies (n=1746)
found no differences in recurrence+mortality for short (<10d) compared to prolonged treatments.
📖 www.journalofhospitalinfection.com/article/S019...
#PsWatch #AMSsky #IDsky
Reposted by Bryan White, PharmD, FIDSA, BCIDP
🧵of beta-lactam antibiotic learning points I developed for learners on rotation. Feedback welcome - there are a ton of brilliant people here who do really cool science in these areas. Would love to learn more! Hope you enjoy this learner-🎯tweetorial #IDSky #PharmSky #PharmEd #MedEd 1/n
November 24, 2024 at 6:56 PM